Meifang Han
- Infectious Diseases top 0.2%
- Neurology top 0.5%
- Epidemiology top 2%
- Immunology top 5%
- Hepatology top 1%
- Co-authors
- Qin NingXiaoping LuoDi WuHongwu WangHuilong ChenHaijing YuWei GuoDa Huang
- Topics
- Hepatitis B Virus Studies (33 papers)Hepatitis C virus research (23 papers)Liver Disease Diagnosis and Treatment (20 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Meifang Han
56 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Infectious Diseases 2.9k
- Neurology 1.6k
- Epidemiology 1.2k
- Immunology 739
- Hepatology 720
Countries citing papers authored by Meifang Han
This map shows the geographic impact of Meifang Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meifang Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meifang Han more than expected).
Fields of papers citing papers by Meifang Han
This network shows the impact of papers produced by Meifang Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meifang Han. The network helps show where Meifang Han may publish in the future.
Co-authorship network of co-authors of Meifang Han
This figure shows the co-authorship network connecting the top 25 collaborators of Meifang Han. A scholar is included among the top collaborators of Meifang Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meifang Han. Meifang Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 57 | |
| 5 | Clinical and immunological features of severe and moderate coronavirus disease 2019breakdown → | 3242 |
| 6 | 8 | |
| 7 | 17 | |
| 8 | 34 | |
| 9 | 13 | |
| 10 | 36 | |
| 11 | 9 | |
| 12 | 15 | |
| 13 | 10 | |
| 14 | 11 | |
| 15 | 5 | |
| 16 | Difficult-to-treat chronic hepatitis B | 1 |
| 17 | 231 | |
| 18 | 25 | |
| 19 | Tax Planning Analysis Based on Listed Company with Different Ownership Structure——The Empirical Evidence from State-owned Listed Company and Private Listed Company in China | 7 |
| 20 | 1 |
About Meifang Han
Meifang Han is a scholar working on Hepatology, Epidemiology and Immunology, having authored 59 papers that have together received 4.9k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (33 papers), Hepatitis C virus research (23 papers) and Liver Disease Diagnosis and Treatment (20 papers). The work is most often cited by research in Infectious Diseases (2.9k citations), Neurology (1.6k citations) and Hepatology (720 citations). Meifang Han has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qin Ning, Xiaoping Luo, Di Wu, Hongwu Wang, Huilong Chen, Haijing Yu, Wei Guo, Da Huang, Jianping Zhao and Tao Chen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.